Bacillus Calmette–Guérin strains with defined resistance mutations: a new tool for tuberculosis laboratory quality control
暂无分享,去创建一个
[1] N. Ismail,et al. Whole genome sequencing for drug resistance determination in Mycobacterium tuberculosis , 2019, African journal of laboratory medicine.
[2] M. English,et al. Variability in distribution and use of tuberculosis diagnostic tests in Kenya: a cross-sectional survey , 2018, BMC Infectious Diseases.
[3] M. Egger,et al. Drug susceptibility testing and mortality in patients treated for tuberculosis in high-burden countries , 2018, bioRxiv.
[4] H. Ait Benhassou,et al. Rapid molecular assays for detection of tuberculosis , 2018, Pneumonia.
[5] Prakash Shrestha,et al. Programmatic Impact of Implementing GeneXpert MTB/ RIF Assay for the Detection of Mycobacterium Tuberculosis in Respiratory Specimens from Pulmonary Tuberculosis Suspected Patients in Resource Limited Laboratory Settings of Eastern Nepal , 2018, The open microbiology journal.
[6] A. d’Arminio Monforte,et al. Incidence and progression to cirrhosis of new hepatitis C virus infections in persons living with human immunodeficiency virus. , 2017, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[7] E. André,et al. Novel rapid PCR for the detection of Ile491Phe rpoB mutation of Mycobacterium tuberculosis, a rifampicin-resistance-conferring mutation undetected by commercial assays. , 2017, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[8] D. Alland,et al. Detection of Isoniazid-, Fluoroquinolone-, Amikacin-, and Kanamycin-Resistant Tuberculosis in an Automated, Multiplexed 10-Color Assay Suitable for Point-of-Care Use , 2016, Journal of Clinical Microbiology.
[9] L. Harrison,et al. Detection of katG and inhA mutations to guide isoniazid and ethionamide use for drug-resistant tuberculosis. , 2016, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[10] Robyn S Lee,et al. Population genomics of Mycobacterium tuberculosis in the Inuit , 2015, Proceedings of the National Academy of Sciences.
[11] T. Ganiats,et al. Frequency and Geographic Distribution of gyrA and gyrB Mutations Associated with Fluoroquinolone Resistance in Clinical Mycobacterium Tuberculosis Isolates: A Systematic Review , 2015, PloS one.
[12] C. Sassetti,et al. Mycobacterial recombineering. , 2015, Methods in molecular biology.
[13] S. Cole,et al. Cross-Resistance between Clofazimine and Bedaquiline through Upregulation of MmpL5 in Mycobacterium tuberculosis , 2014, Antimicrobial Agents and Chemotherapy.
[14] J. Nkengasong,et al. Laboratory Diagnosis of Tuberculosis in Resource-Poor Countries: Challenges and Opportunities , 2011, Clinical Microbiology Reviews.
[15] S. Narayanan,et al. Mutations in the rpoB Gene of Multidrug-Resistant Mycobacterium tuberculosis Clinical Isolates from India , 2001, Journal of Clinical Microbiology.